相关实验视频
Updated: Jul 6, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.6K
MSFF-MA-DDI:多源特征融合与多重注意力块用于预测药物相互作用事件
Qi Jin1, Jiang Xie1, Dingkai Huang1
1School of Computer Engineering and Science, Shanghai University, Shanghai, 200444, China.
Computational biology and chemistry
|December 28, 2023
概括
本研究介绍了MSFF-MA-DDI,这是一个用于预测药物相互作用 (DDI) 的新框架. 它有效地整合了全球分子特征和多源数据,提高了预测准确度,特别是在具有挑战性的冷启动场景中.
科学领域:
- 计算化学是一种计算化学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 药物相互作用 (DDI) 具有重大风险,导致不良医疗事件和增加医疗保健成本.
- 准确的DDI预测对于临床决策和优化患者治疗至关重要.
- 当前的DDI预测模型往往忽视了全球分子特征和多源数据集成.
研究的目的:
- 开发一个先进的框架,MSFF-MA-DDI,用于预测药物相互作用 (DDI).
- 通过结合全球分子特征和融合多来源药物数据来解决现有模型的局限性.
- 为了提高DDI事件预测的准确性和稳定性.
主要方法:
- 设计了多源特征融合与多重注意力块 (MSFF-MA-DDI) 框架.
- 利用具有位置嵌入的自我注意机制来捕捉药物序列中的远程原子相关性.
- 综合药物序列特征具有异质数据 (化学子结构,标,酶) 通过多头注意力块.
主要成果:
- 在现实数据集上,MSFF-MA-DDI实现了与最先进模型相美或超过的性能.
- 该模型在冷启动场景中表现出卓越的性能,优于现有方法.
- 一个涉及神经系统药物的案例研究证实了该模型的有效性.
结论:
- MSFF-MA-DDI通过有效利用全球和多来源药物特征,为DDI事件预测提供了一种强大的方法.
- 该框架对临床应用具有显著的前景,特别是在管理复杂的多药和解决数据稀缺方面.
- 该研究为研究人员和临床医生提供了一种有价值的工具,旨在减轻DDI风险.
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Drug-Receptor Interaction: Antagonist
3.0K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.0K
Agonism and Antagonism: Quantification
377
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
377

